COM:AWAKNLIFESCIENCES

Awakn Life Sciences

Stock

CAD

Last Close

0.14

12/02 20:59

Market Cap

4.44M

Beta: -

Volume Today

7.32K

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Jan '22	Jan '23
net income	-16.47M -	-9.65M 41.41%
depreciation and amortization	181.41K -	603.53K 232.69%
deferred income tax	5.08M -	897.78K 82.34%
stock based compensation	1.09M -	628.23K 42.38%
change in working capital	537.66K -	509.78K 5.18%
accounts receivables	-2.58K -	-15.52K 502.13%
inventory	-1.02M -	-650.05K 36.47%
accounts payables	1.02M -	650.05K 36.47%
other working capital	540.24K -	525.30K 2.76%
other non cash items	993.55K -	-351.35K 135.36%
net cash provided by operating activities	-8.59M -	-7.36M 14.24%
investments in property plant and equipment	-1.71M -	-95.34K 94.41%
acquisitions net	21.65K -
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites	-1.69M -	-95.34K 94.34%
debt repayment	-174.79K -	-332.73K 90.36%
common stock issued	7.49M -	5.97M 20.27%
common stock repurchased
dividends paid
other financing activites	4.19M -	766.09K 81.71%
net cash used provided by financing activities	11.50M -	6.40M 44.32%
effect of forex changes on cash	27.25K -	-16.93K 162.14%
net change in cash	1.26M -	-1.07M 185.30%
cash at beginning of period	366.06K -	1.62M 343.42%
cash at end of period	1.62M -	550.87K 66.06%
operating cash flow	-8.59M -	-7.36M 14.24%
capital expenditure	-1.71M -	-95.34K 94.41%
free cash flow	-10.29M -	-7.46M 27.54%

All numbers in CAD (except ratios and percentages)